Inveresk Research Group has shuffled the responsibilities of two of its top executives.

The drug development services provider named Alastair McEwan as president of its worldwide clinical operations. Previously, he had been president of the Americas clinical division.

Nicholas Thornton, president of clinical operations in Europe and Asia Pacific, was named head of corporate development.